A. Cheng

Hepatology · The Lancet Oncology · 2001–2022

A researcher in the Science corpus: 16 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom A. Cheng trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Jordi Bruix1 , 2
  2. J. Llovet
  3. Riccardo Lencioni

Who trusts A. Cheng overall

  1. Jordi Bruix1 , 2
  2. Amit G. Singal
  3. Julie S. Jurenka
  4. J. Llovet
  5. Bharat B. Aggarwal
  6. Hongyu Zhou
  7. M. Sherman
  8. Ricky A. Sharma
  9. Alejandro Forner1 , 2
  10. Peter R. Galle

Papers from A. Cheng's perspective

Ordered by how strongly the researchers A. Cheng trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. (Gastroenterology)
  2. Novel advancements in the management of hepatocellular carcinoma in 2008. (Journal of Hepatology)
  3. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. (American Journal of Epidemiology)
  4. The natural history of compensated cirrhosis due to hepatitis C virus: A 17‐year cohort study of 214 patients (Hepatology)
  5. Noninvasive assessment of liver fibrosis (Hepatology)
  6. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. (Journal of Hepatology)
  7. Molecular Targeted Therapies in Hepatocellular Carcinoma (Hepatology)
  8. Long-Term Survival and Pattern of Recurrence After Resection of Small Hepatocellular Carcinoma in Patients With Preserved Liver Function: Implications for a Strategy of Salvage Transplantation (Annals of Surgery)
  9. Diagnosis and treatment of hepatocellular carcinoma. (Gastroenterology)
  10. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival (Hepatology)

Their papers